Literature DB >> 334789

Pituitary-ovarian relationships in polycystic ovary syndrome.

D T Baird, C S Corker, D W Davidson, W M Hunter, E A Michie, P F Van Look.   

Abstract

The spontaneous pattern of pituitary gonadotropins and ovarian steroids and their response to dynamic tests were measured in 12 women with polycystic ovarian syndrome (PCO) and the results compared to those from 6 normal women during the early follicllar phase of the cycle (controls). As judged by serial measurements of urinary total estrogen and pregnanediol over a 12-week period, in PCO patients 75% of cycles were anovulatory (anovulatory PCO) as compared to 100% ovulatory in controls. The basal concentrations of LH, androstenedione and estrone were significantly higher and the concentration os FSH significantly lower in anovulatory PCO than in the controls (P less than .05). In PCO patients the concentration of LH was lower following an ovulatory cycle than that following a period of anovulation. Negative and positive feedback responses to an estrogen provocation test (200 microgram ethinyl estradiol per day for 3 days) were normal in anovulatory PCO although the LH peak occurred 24 h earlier than in the controls. The amplitude of the pulses of LH was significantly greater in anovulatory PCO than in the controls and was suppressed in both groups after ethinyl estradiol. The peak release of LH in response to 56 microgram LRF in ovulatory PCO was similar in controls but LH responses in anovulatory PCO were significantly greater. It is suggested that the abnormalities in gonadotropin secretion in PCO are secondary to excessive and prolonged extraglandular production of estrogen from androstenedione.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 334789     DOI: 10.1210/jcem-45-4-798

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Luteinising hormone in polycystic ovary syndrome.

Authors:  E Turner; M C White
Journal:  BMJ       Date:  1989-01-14

2.  Polycystic ovary syndrome: an enigma awaiting solution.

Authors:  M Schwartz; P R Gindoff; R Jewelewicz
Journal:  Bull N Y Acad Med       Date:  1987-03

Review 3.  Hypersecretion of luteinizing hormone in the polycystic ovary syndrome and a novel hormone 'gonadotrophin surge attenuating factor'.

Authors:  A H Balen
Journal:  J R Soc Med       Date:  1995-06       Impact factor: 5.344

Review 4.  Hirsutism and the effectiveness of spironolactone in its management.

Authors:  G R McMullen; A J Van Herle
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

5.  Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.

Authors:  Susan Sam; Priyathama Vellanki; Sudha K Yalamanchi; Richard N Bergman; Andrea Dunaif
Journal:  Metabolism       Date:  2017-03-22       Impact factor: 8.694

Review 6.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

7.  Pituitary and adrenal response to ovine corticotropin-releasing hormone in women with polycystic ovarian syndrome.

Authors:  A Mongioì; M Macchi; E Vicari; M C Fornito; A E Calogero; C Riccioli; G Minacapilli; M L Moncada; R D'Agata
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

8.  A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.

Authors:  N O Turhan; P G Artini; G D'Ambrogio; F Droghini; C Battaglia; A D Genazzani; A Volpe; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

9.  Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys.

Authors:  David H Abbott; Deborah K Barnett; Jon E Levine; Vasantha Padmanabhan; Daniel A Dumesic; Steve Jacoris; Alice F Tarantal
Journal:  Biol Reprod       Date:  2008-04-02       Impact factor: 4.285

Review 10.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.